Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A phase I Trial of concurrent Taxol and BID radiotherapy with and without Ethyol in patients with advanced squamous cell carcinoma of the head and neck

A phase I Trial of concurrent Taxol and BID radiotherapy with and without Ethyol in patients with advanced squamous cell carcinoma of the head and neck. ASCO. 2000; 418 (#1651).


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.